• Fri news: New Novo obesity prospect linked to psychiatric side effects. Summit beats Keytruda in NSCLC. DermaSensor skin cancer detection device. Astellas digital health product. Sanofi MS data. See more on our front page

Roche cracks China's ADC market open as Kadcyla scores its first breast cancer OK in...

Quote
cafead

cafead

Administrator
Staff member
  • cafead   Jan 23, 2020 at 12:22: PM
via Roche’s Kadcyla has become the first antibody-drug conjugate to enter the Chinese market, marking a dramatic advance for both the Swiss pharma giant and the therapeutic class.

article source
 

<



Similar threads

cafead
Roche reports positive data from Phase III influenza treatment trial
Replies
0
Views
7
Pharma/Biotech Companies - In the News
cafead
cafead
cafead
Obesity pill race heats up as Novo, Roche and Terns share data
Replies
0
Views
43
Pharma/Biotech Companies - In the News
cafead
cafead
cafead
Roche doubles down with another subcutaneous FDA nod, this one for MS star Ocrevus
Replies
0
Views
33
Pharma/Biotech Companies - In the News
cafead
cafead
cafead
FDA approves Roche’s Tecentriq Hybreza for cancer
Replies
0
Views
21
Pharma/Biotech Companies - In the News
cafead
cafead
cafead
‘The trajectory is encouraging.’ Roche hopes obesity drug will show 25% weight loss one day
Replies
1
Views
71
Pharma/Biotech Companies - In the News
anonymous
Top Bottom
Back
Quote